Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|December 19, 2021
Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor-based regimens in children and adolescents in KenyaLeonard Kingwara, Seth C Inzaule, Lazarus Momanyi, et al.
World Journal of AIDS|February 10, 2015
HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low LevelsMichael R Jordan, Julie Winsett, Aileen Tiro, et al.
Viruses|September 28, 2023
Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping ReviewKaiming Tao, Soo-Yon Rhee, Carolyn Chu, et al.
Plos One|May 7, 2019
Effectiveness of symptom-based diagnostic HIV testing versus targeted and blanket provider-initiated testing and counseling among children and adolescents in CameroonHabakkuk A Yumo, Rogers A Ajeh, Marcus Beissner, et al.
Plos One|April 14, 2020
Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in CameroonHabakkuk A Yumo, Rogers A Ajeh, Isidore Sieleunou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2011
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoringJames H McMahon, Michael R Jordan, Karen Kelley, et al.
Antiviral Research|April 22, 2014
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settingsNicolas Sluis-Cremer, Michael R Jordan, Kelly Huber, et al.
Journal of AIDS & Clinical Research|March 16, 2013
Knowledge of HIV Transmission and Associated Factors among HIV-Positive and HIV-Negative Patients in Rural KenyaSteven Y Hong, Daria Thompson, Christine Wanke, et al.
Plos One|July 3, 2014
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidanceAnna Jonas, Victor Sumbi, Samson Mwinga, et al.
Antiviral Therapy|February 12, 2019
Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methodsGillian M Hunt, Johanna Ledwaba, Monalisa Kalimashe, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|December 19, 2021
Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor-based regimens in children and adolescents in KenyaLeonard Kingwara, Seth C Inzaule, Lazarus Momanyi, et al.
World Journal of AIDS|February 10, 2015
HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low LevelsMichael R Jordan, Julie Winsett, Aileen Tiro, et al.
Viruses|September 28, 2023
Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping ReviewKaiming Tao, Soo-Yon Rhee, Carolyn Chu, et al.
Plos One|May 7, 2019
Effectiveness of symptom-based diagnostic HIV testing versus targeted and blanket provider-initiated testing and counseling among children and adolescents in CameroonHabakkuk A Yumo, Rogers A Ajeh, Marcus Beissner, et al.
Plos One|April 14, 2020
Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in CameroonHabakkuk A Yumo, Rogers A Ajeh, Isidore Sieleunou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2011
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoringJames H McMahon, Michael R Jordan, Karen Kelley, et al.
Antiviral Research|April 22, 2014
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settingsNicolas Sluis-Cremer, Michael R Jordan, Kelly Huber, et al.
Journal of AIDS & Clinical Research|March 16, 2013
Knowledge of HIV Transmission and Associated Factors among HIV-Positive and HIV-Negative Patients in Rural KenyaSteven Y Hong, Daria Thompson, Christine Wanke, et al.
Plos One|July 3, 2014
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidanceAnna Jonas, Victor Sumbi, Samson Mwinga, et al.
Antiviral Therapy|February 12, 2019
Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methodsGillian M Hunt, Johanna Ledwaba, Monalisa Kalimashe, et al.
Pageof 11